Search

Your search keyword '"Scleroderma, Systemic mortality"' showing total 496 results

Search Constraints

Start Over You searched for: Descriptor "Scleroderma, Systemic mortality" Remove constraint Descriptor: "Scleroderma, Systemic mortality"
496 results on '"Scleroderma, Systemic mortality"'

Search Results

1. Long-term outcome of autologous haematopoietic stem cell transplantation in patients with systemic sclerosis: a comparison with patients treated with rituximab and with traditional immunosuppressive agents.

2. Comorbidity burden on mortality in patients with systemic sclerosis.

3. Quantitative chest computed tomography predicts mortality in systemic sclerosis: A longitudinal study.

4. Systemic sclerosis sine scleroderma is more aggressive in children than in adults.

5. Arrhythmia in patients with systemic sclerosis: incidence, risk factors and impact on mortality in a Swedish register-based study.

6. Long-term organ damage accrual and late mortality in systemic sclerosis.

7. Investigating the trajectory of functional disability in systemic sclerosis: group-based trajectory modelling of the Health Assessment Questionnaire-Disability Index.

8. Systemic sclerosis is associated with increased in-patient mortality in patients hospitalized for heart failure.

9. Safety and Tolerability of Rituximab in the Treatment of Systemic Sclerosis.

10. Prediction of prognosis in patients with systemic sclerosis based on a machine-learning model.

11. Autoantibodies in systemic sclerosis overlap syndrome and their correlation with organ damage and survival.

12. Successful long-term systemic sclerosis treatment by high-frequent low-dose B cell-depleting therapy.

13. Causes and predictors of death among Finnish patients with systemic sclerosis.

14. Evaluation of the European Society of Cardiology Risk Assessment Score in Incident Systemic Sclerosis-Associated Pulmonary Arterial Hypertension.

15. Progressive pulmonary fibrosis and its impact on survival in systemic sclerosis-related interstitial lung disease.

16. A Prospective Observational Study of Disease Severity and Mortality in Hispanic American Patients With Systemic Sclerosis.

17. Anti-U1RNP antibodies are associated with a distinct clinical phenotype and a worse survival in patients with systemic sclerosis.

18. Survival in systemic sclerosis associated pulmonary arterial hypertension in the current treatment era-results from a nationwide study.

19. Untangling the relationship between smoking and systemic sclerosis: an analysis of the EUSTAR cohort.

20. Prognostic significance of pericardial effusion in systemic sclerosis-associated pulmonary hypertension: analysis from the PHAROS Registry.

21. Contribution of Left Ventricular Diastolic Dysfunction to Survival and Breathlessness in Systemic Sclerosis-Associated Interstitial Lung Disease.

22. Pulmonary arterial hypertension in systemic sclerosis: a national inpatient analysis.

24. Preliminary results on long-term follow-up of systemic sclerosis patients under extracorporeal photopheresis.

25. Digital pitting scars are associated with a severe disease course and death in systemic sclerosis: a study from the EUSTAR cohort.

26. Interventricular systolic asynchrony predicts prognosis in patients with systemic sclerosis-associated pulmonary arterial hypertension.

27. Intravenous prostanoids in systemic sclerosis-associated pulmonary arterial hypertension: a single-centre experience.

28. Cardiopulmonary exercise testing and prognosis in patients with systemic sclerosis without baseline pulmonary hypertension: a prospective cohort study.

29. Increased malignancies in systemic sclerosis.

30. Anti-RNPC-3 antibody predicts poor prognosis in patients with interstitial lung disease associated to systemic sclerosis.

31. Estimated glomerular filtration rate is a marker of mortality in the European Scleroderma Trials and Research Group (EUSTAR) database.

32. Connective Tissue Disease-Interstitial Lung Disease-Associated Mortality Rates and Years of Potential Life Lost in the United States.

33. Trends in Systemic Sclerosis Mortality Over Forty-Eight Years, 1968-2015: A US Population-Based Study.

34. Regulation of Monocyte Adhesion and Type I Interferon Signaling by CD52 in Patients With Systemic Sclerosis.

35. Epidemiology of systemic sclerosis in the UK: an analysis of the Clinical Practice Research Datalink.

36. Clinical Features of Systemic Sclerosis-Mixed Connective Tissue Disease and Systemic Sclerosis Overlap Syndromes.

37. Aerosol components associated with hospital mortality in systemic sclerosis: an analysis from a nationwide Thailand healthcare database.

38. Laser speckle contrast analysis predicts major vascular complications and mortality of patients with systemic sclerosis.

39. Cost-Effectiveness of Combination Therapy for Patients With Systemic Sclerosis-Related Pulmonary Arterial Hypertension.

40. Treatment of systemic sclerosis.

41. Autologous stem cell transplantation in scleroderma.

42. Hematopoietic stem cell transplantation for systemic sclerosis: Brazilian experience.

43. Exercise Pulmonary Resistances Predict Long-Term Survival in Systemic Sclerosis.

44. Incidence, prevalence and mortality of systemic sclerosis in Italy: a nationwide population-based study using administrative health data.

45. Emerging drugs for the treatment of scleroderma: a review of recent phase 2 and 3 trials.

46. Hydroxychloroquine and maintenance immunosuppression use in kidney transplant recipients: Analysis of linked US registry and claims data.

47. Current immunosuppressive and antifibrotic therapies of systemic sclerosis and emerging therapeutic strategies.

48. Relationship between calcifications and structural lesions on hand radiography and axial calcifications on CT-scan: A retrospective study in systemic sclerosis.

49. Myopathy is a Risk Factor for Poor Prognosis of Patients with Systemic Sclerosis: A retrospective cohort study.

50. Predictive factors for treatment-related mortality and major adverse events after autologous haematopoietic stem cell transplantation for systemic sclerosis: results of a long-term follow-up multicentre study.

Catalog

Books, media, physical & digital resources